The Likely Reality Both hormones probably matter, but in different ways
Materials and Methods Study Design and Setting This retrospective study utilized prospectively collected data from patients treated at our bariatric surgery center between January 2019 and October 2023
Therefore, theres a need for oral treatment options with weight-reduction efficacy similar to that of the approved and currently available injectable GLP-1 receptor agonists. Promising phase-two trials suggest orforglipron could help meet this need
How the Field of Dietetics and Nutrition Could Take off With the Popularity of GLP-1 Obesity Treatments Finding that happy medium is exactly where the opportunity emerges for dietitians and nutritionists
They represent a new option that wasnt available even a few years ago
Last, we call upon clinicians, researchers, regulators, and industry stakeholders to address existing gaps in accessibility and explore opportunities for enhancing the use of GLP-1R agonists in both individualized care and broader public health contexts